Company: ZCARW
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001213900-25-110391
Chunk: 49

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 49
---
18,186) 
    $46,101 
  
    Recognized during the period, net of taxes amounts to $NIL 
     (22,471) 
     (57,663)
  
    Reclassification to net income: Amortization gains 
     (598) 
     (6,624)
  
    Balance, end of period 
    $(41,255) 
    $(18,186)

    Foreign currency translation adjustment 

    Balance, beginning of period 
    $2,149,708  
    $1,749,891 
  
    Translation adjustment on derecognition of subsidiary 
     (1,404,376) 
     - 
  
    Translation adjustments gain recognized during the period, net of taxes amounts to $NIL 
     589,448  
     399,817 
  
    Balance, end of period 
    $1,334,780  
    $2,149,708 
  
    Accumulated other comprehensive income 
    $1,293,525  
    $2,131,522 

(This
space has been left intentionally blank)

36

ZOOMCAR
HOLDINGS, INC.

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

18Capital
                                            Stock and Warrants

During
the year ended March 31,2025, the Company executed four equity offerings. These offerings involved the sale of Common Stock, Pre-Funded
Warrants, Series A Warrants and a maximum number of Series B Warrants as defined in the respective agreements.

Holders
of common stock are entitled to one vote per share, dividends at the discretion of the Board of Directors, and a pro-rata share of residual
assets upon liquidation. This comprehensive activity reflects the Company’s capital restructuring and financing strategy during
the reporting period.

Series
A warrants were issued with initial exercise prices of $80.60, $39.00, and $6.24, each exercisable for five years from the initial exercise
date. Series B warrants were issued with zero initial eligibility, subject to increase on the Reset Date based on the Reset Share Amount
formula. Placement agents received 10% of the Series A and Series B warrants issued to investors, along with Common Stock Warrants, as
compensation. The Company classified all Series A and Series B warrants as derivative financial instruments under ASC 815-10-15-83 upon